DENTSPLY SIRONA Inc.(XRAY) Stock Research - Grey Stern Research

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis

$13.81 (0.40%)

XRAY Financial Performance


Use the table below to view DENTSPLY SIRONA Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q3 - 2024

Metric Value Ranking among Peers
Price $13.75 -
52 Week Low $12.16 -
52 Week High $31.00 -
Market Cap $2.7 Billion 10/11
Gross Margin 49% 7/11
Profit Margin -48% 11/11
EBITDA margin -56% 11/11
Q3 - 2024 Revenue $905.0 Million 5/11
Q3 - 2024 Earnings -$430.0 Million 11/11
Q3 - 2024 Free Cash Flow $0 Million 10/11
Trailing 4 Quarters Revenue $3.8 Billion 5/11
Trailing 4 Quarters Earnings -$910.0 Million 11/11
Quarterly Earnings Growth 0% 7/11
Annual Earnings Growth -14% 8/11
Quarterly Revenue Growth 5556% 1/11
Annual Revenue Growth 33% 2/11
Cash On Hand $272.0 Million 9/11
Short Term Debt $549.0 Million 2/11
Long Term Debt $1.7 Billion 3/11

DENTSPLY SIRONA Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare DENTSPLY SIRONA Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE -1.00 9/11
PS 0.72 11/11
PB 1.41 10/11
PC 10.06 8/11
Liabilities to Equity 1.96 1/11
ROA -0.16 11/11
ROE -0.47 11/11
Current Ratio 1.51 11/11
Quick Ratio 0.07 9/11
Long Term Debt to Equity 0.86 2/11
Debt to Equity 1.15 2/11
Burn Rate 0.43 8/11
Cash to Cap 0.10 3/11
CCR 10/11
EV to EBITDA -9.21 9/11
EV to Revenue 1.24 10/11

Company Details

DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces. The company also provides dental CAD/CAM products, digital impressions intraoral scanners, mills, and services; and orthodontic products, including high frequency vibration technology device under the name VPro, dentist-directed clear aligner solutions under the name SureSmile, and direct-to-consumer clear aligner solutions under the name Byte; dental implant products, bone regenerative and restorative solutions, and educational programs; and urology catheters and other healthcare-related consumable products. In addition, it offers endodontic products comprising endodontic instruments and materials, drills, filers, sealers, irrigation needles, and other tools or single-use solutions; restorative products that include dental prosthetics, such as artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products; small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers; and dental supplies, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.

CEO: Mr. Donald Casey

Website: https://www.dentsplysirona.com

Address: 13320 Ballantyne Corporate Pl Charlotte, NORTH CAROLINA

Exchange: NASDAQ Global Select

Industry: Medical Instruments & Supplies

DENTSPLY SIRONA Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to DENTSPLY SIRONA Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Becton, Dickinson and Company BDX $58.9 Billion
Hologic, Inc. HOLX $13.0 Billion
ResMed Inc. RMD $34.6 Billion
The Cooper Companies, Inc. COO $16.2 Billion
Haemonetics Corporation HAE $3.1 Billion
Teleflex Incorporated TFX $6.0 Billion
West Pharmaceutical Services, Inc. WST $15.5 Billion
Merit Medical Systems, Inc. MMSI $5.6 Billion
AngioDynamics, Inc. ANGO $389.8 Million
ICU Medical, Inc. ICUI $3.3 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
XRAY Income Statements
Quarter Year Revenue Earnings
Q4 2024 $ 905.0 Million -$430.0 Million
Q3 2024 $ 951.0 Million -$494.0 Million
Q2 2024 $ 984.0 Million -$4.0 Million
Q1 2024 $ 953.0 Million $18.0 Million
Q4 2023 $ 16.0 Million $0
Q3 2023 $ 947.0 Million -$266.0 Million
Q2 2023 $ 1.0 Billion $86.0 Million
Q1 2023 $ 978.0 Million -$23.0 Million

View All

XRAY Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q4 2024 $272.0 Million $5.8 Billion $2.2 Billion $1.9 Billion
Q3 2024 $296.0 Million $6.6 Billion $2.3 Billion $2.5 Billion
Q2 2024 $279.0 Million $6.9 Billion $2.2 Billion $3.1 Billion
Q1 2024 $291.0 Million $7.1 Billion $2.2 Billion $3.3 Billion
Q4 2023 $334.0 Million $7.4 Billion $2.2 Billion $3.3 Billion
Q3 2023 $309.0 Million $7.2 Billion $2.1 Billion $3.4 Billion
Q2 2023 $295.0 Million $7.7 Billion $2.2 Billion $3.7 Billion
Q1 2023 $318.0 Million $7.7 Billion $2.3 Billion $3.6 Billion

View All

XRAY Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q3 2024 $98.0 Million -$43.0 Million $17.0 Million
Q2 2024 $156.0 Million -$52.0 Million -$12.0 Million
Q1 2024 -$9.0 Million -$34.0 Million -$43.0 Million
Q4 2023 $120.0 Million -$40.0 Million $120.0 Million
Q3 2023 $97.0 Million -$37.0 Million $97.0 Million
Q2 2023 $71.0 Million -$33.0 Million -$23.0 Million
Q1 2023 -$60.0 Million -$39.0 Million -$47.0 Million
Q4 2022 $110.0 Million -$32.0 Million -$53.0 Million

View All

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions